.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Stakeholders

Academia
Employers
Health System
Payers
Providers

Topics

Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Institute for Value-Based Medicine

All Coverage
Event Coverage
Interviews
News

About AJMC

AJMC Journals
Anniversary
Author Forms
Authors
Nominate a Rising Leader

About Us
Contact
Editorial Staff
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy

Interactive Publications

Matching-adjusted Indirect Comparison for Treatment of TRK Fusion Cancer with Larotrectinib versus Entrectinib

Efficacy and safety profile of tezepelumab-ekko: results from the phase 3 NAVIGATOR

Interactive Publications

Matching-adjusted Indirect Comparison for Treatment of TRK Fusion Cancer with Larotrectinib versus Entrectinib

Efficacy and safety profile of tezepelumab-ekko: results from the phase 3 NAVIGATOR

Mitigating Cardiovascular Risk Through Lipid Management: From Hospital to Home